Bipartisan leaders introduced Senate Bill S. 545 to empower the DEA to track the manufacturing of illicit substances, specifically addressing issues like xylazine.
5 reports, 2 independent
Updated Sep 17
Gone quiet
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bipartisan leaders introduced Senate Bill S. 545 to empower the DEA to track the manufacturing of illicit substances, specifically addressing issues like xylazine.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Riley voted for the Senate bill empowering the DEA to track xylazine.1 source
Introduced S. 545 enabling DEA to track manufacturing of illicit drugs like xylazine.1 source